Hoch sensitive molekularbiologische Tests zur minimal-invasiven Diagnose und Nachsorge von Hodenkrebs mit dem M371-Test. mir|detect
Location: Germany, Bremen
Employees: 1-10
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | MediVentur... | medi.ventu... |
| - | High-Tech ... | htgf.de |
Mentions in press and media 2
| Date | Title | Description |
| 02.05.2019 | miRdetect Raises Seven-Digit Seed Funding | miRdetect, a Bremen, Germany-based startup that develops a test method for the detection of testicular cancer, raised a seven-figure sum in seed funding. Backers High-Tech Gründerfonds, BAB Beteiligungs- und Managementgesellschaft Bremen mb... |
| - | miRdetect Receives Seed Financing – Consortium Invests Seven-Digit Amount in Serum Marker for Testicular Cancer Detection | Together with BBM and a private investor, High-Tech Gründerfonds (HTGF) is investing a seven-figure sum in the start-up company miRdetect located in Bremen, and founded in 2016. The company founders Meike Spiekermann and Dr. Nina Winter wer... |